Viktor P Volok (V P Volok)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Dendritic Cells

Tyrosine Kinase

Top Venues

Emerging microbes & infections

Human vaccines & immunotherapeutics

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Chumakov Institute of Poliomyelitis and Viral Encephalitides

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chumakov Institute of Poliomyelitis and Viral Encephalitides

Russia

Junior Researcher

Publications

T V Kirychenko, N V Turkot, M S Dodina, Viktor P Volok, I K Belyaletdinova
[Viral meningoencephalitis with damage to the right temporal lobe with a favorable outcome]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (3) (2022)
Liubov I Kozlovskaya, Anastasia N Piniaeva, Georgy M Ignatyev, Ilya V Gordeychuk, Viktor P Volok, Yulia V Rogova, Anna A Shishova, Anastasia A Kovpak, Yury Yu Ivin, Liliya P Antonova, Kirill M Mefyod, Lyubov S Prokosheva, Anna S Sibirkina, Yuliya Yu Tarasova, Ekaterina O Bayurova, Olga S Gancharova, Victoria V Illarionova, Grigory S Glukhov, Olga S Sokolova, Konstantin V Shaitan, Anastasia M Moysenovich, Stanislav A Gulyaev, Tatiana V Gulyaeva, Andrey V Moroz, Larissa V Gmyl, Elena G Ipatova, Mikhail P Kirpichnikov, Alexey M Egorov, Aleksandra A Siniugina, Aidar A Ishmukhametov
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies. Emerging microbes & infections 10 (1) (2021)
Mikhail F Vorovitch, Karina G Grishina, Viktor P Volok, Liubov L Chernokhaeva, Konstantin V Grishin, Galina G Karganova, Aidar A Ishmukhametov
Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture. Human vaccines & immunotherapeutics 16 (9) (2020)